Abbott boosts dividends and highlights steady growth, reflecting strong shareholder return policies and financial health.

Abbott Laboratories closed $6.14 below its 52-week high ($121.64), which the company achieved on March 8th.

Abbott Laboratories closed $6.74 below its 52-week high ($121.64), which the company achieved on March 8th.

Abbott (ABT) announced that its board of directors has increased the company’s quarterly common dividend to 59c per share, an increase of 7.3%.

In a report released today, Suraj Kalia from Oppenheimer maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a price ...

Over the past year, many Abbott Laboratories ( NYSE:ABT ) insiders sold a significant stake in the company which ...

Abbott Laboratories (ABT) stock saw a decline, ending the day at $113.86 which represents a decrease of $-0.28 or -0.25% from the prior close of $114.14. The stock opened at $114.31 and touched a low ...

We recently compiled a list of the 8 Best Dividend Kings To Invest In For Safe Dividend Growth. In this article, we are going ...

Jim Cramer discusses Occidental Petroleum, Cooper Companies, Energy Transfer, Abbott, Kinder Morgan, Advanced Drainage and ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.66% of ...

Abbott Laboratories (NYSE:ABT – Get Free Report) saw a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 12,050,000 shares, a ...